Skip to Main Content

Paper Details

Neuropsychological Testing Predicts Cerebrospinal Fluid Amyloid-β in Mild Cognitive Impairment.
J Alzheimers Dis
21
2015
AD, Alzheimer's Disease, Alzheimer's disease, CSF, FDG, MCI, Mild Cognitive Impairment, amyloid- (A)1 - 42, cerebrospinal fluid (CSF, hippocampal, mild cognitive impairment, patients
Author NameAffiliation
Brian B AvantsPerelman School of Medicine of the University of Pennsylvania
James C GeePerelman School of Medicine of the University of Pennsylvania
James C GeePerelman School of Medicine of the University of Pennsylvania
Steven E ArnoldPerelman School of Medicine of the University of Pennsylvania
David A WolkPerelman School of Medicine of the University of Pennsylvania
  • 1 - 5

Datasets